Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.22M Sell
20,508
-498
-2% -$178K 0.24% 97
2025
Q4
$6.88M Sell
21,006
-820
-4% -$260K 0.24% 93
2025
Q3
$6.16M Sell
21,826
-9,070
-29% -$2.63M 0.22% 99
2025
Q2
$8.63M Buy
30,896
+4,782
+18% +$1.35M 0.33% 67
2025
Q1
$8.14M Buy
26,114
+1,097
+4% +$324K 0.33% 67
2024
Q4
$6.52M Sell
25,017
-1,466
-6% -$435K 0.27% 82
2024
Q3
$8.53M Sell
26,483
-236
-0.9% -$77.2K 0.35% 64
2024
Q2
$8.35M Buy
26,719
+964
+4% +$283K 0.37% 60
2024
Q1
$7.32M Buy
25,755
+864
+3% +$253K 0.33% 70
2023
Q4
$7.17M Sell
24,891
-786
-3% -$214K 0.36% 65
2023
Q3
$6.9M Buy
25,677
+283
+1% +$70.6K 0.38% 66
2023
Q2
$5.64M Buy
25,394
+4,862
+24% +$1.13M 0.31% 76
2023
Q1
$4.96M Buy
20,532
+118
+0.6% +$29K 0.31% 77
2022
Q4
$5.36M Sell
20,414
-98
-0.5% -$26.3K 0.35% 71
2022
Q3
$4.62M Buy
20,512
+2,046
+11% +$496K 0.33% 76
2022
Q2
$4.49M Buy
18,466
+1,740
+10% +$426K 0.31% 79
2022
Q1
$4.04M Buy
16,726
+1,688
+11% +$388K 0.25% 95
2021
Q4
$3.38M Sell
15,038
-4,437
-23% -$936K 0.2% 111
2021
Q3
$4.14M Buy
19,475
+574
+3% +$132K 0.27% 93
2021
Q2
$4.61M Buy
18,901
+3,143
+20% +$773K 0.3% 82
2021
Q1
$3.92M Buy
15,758
+4,451
+39% +$1.06M 0.28% 88
2020
Q4
$2.6M Buy
11,307
+280
+3% +$64.6K 0.2% 107
2020
Q3
$2.8M Buy
11,027
+470
+4% +$116K 0.25% 91
2020
Q2
$2.49M Buy
10,557
+466
+5% +$106K 0.23% 100
2020
Q1
$2.05M Buy
10,091
+444
+5% +$97K 0.23% 103
2019
Q4
$2.33M Buy
9,647
+1,537
+19% +$339K 0.21% 116
2019
Q3
$1.57M Sell
8,110
-155
-2% -$29.8K 0.15% 142
2019
Q2
$1.52M Sell
8,265
-733
-8% -$131K 0.15% 141
2019
Q1
$1.71M Sell
8,998
-3,605
-29% -$688K 0.18% 131
2018
Q4
$2.45M Buy
12,603
+720
+6% +$140K 0.29% 90
2018
Q3
$2.44M Sell
11,883
-1,376
-10% -$271K 0.28% 91
2018
Q2
$2.45M Buy
13,259
+4,386
+49% +$776K 0.3% 86
2018
Q1
$1.51M Buy
8,873
+1,417
+19% +$260K 0.43% 57
2017
Q4
$1.3M Sell
7,456
-284
-4% -$50.3K 0.51% 53
2017
Q3
$1.44M Buy
7,740
+1,087
+16% +$193K 0.57% 50
2017
Q2
$1.15M Buy
6,653
+368
+6% +$59.9K 0.47% 63
2017
Q1
$1.03M Buy
6,285
+1,405
+29% +$233K 0.43% 67
2016
Q4
$713K Buy
4,880
+664
+16% +$99.9K 0.32% 95
2016
Q3
$704K Buy
4,216
+18
+0.4% +$3.04K 0.3% 102
2016
Q2
$639K Sell
4,198
-1,758
-30% -$273K 0.28% 110
2016
Q1
$893K Buy
5,956
+5
+0.1% +$743 0.43% 67
2015
Q4
$966K Buy
5,951
+209
+4% +$32.9K 0.48% 63
2015
Q3
$794K Hold
5,742
0.45% 70
2015
Q2
$882K Buy
5,742
+1,054
+22% +$169K 0.44% 69
2015
Q1
$749K Buy
4,688
+280
+6% +$44.1K 0.38% 81
2014
Q4
$702K Buy
+4,408
New +$687K 0.42% 69

Other funds holding AMGN

Argent Trust Co's AMGN Position: Q1 2026 in Review

Argent Trust Co reduced its Amgen (AMGN) stake by 2.4% in Q1 2026, selling an estimated $178K and leaving 20,508 shares worth $7.22M. The position accounts for 0.24% of the portfolio, ranked #97.

Argent Trust Co first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $8.63M in Q2 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Argent Trust Co held 20,508 shares of Amgen worth $7.22M as of Q1 2026.
  • Argent Trust Co sold 498 Amgen shares in Q1 2026, an estimated $178K.
  • Amgen made up 0.24% of Argent Trust Co's portfolio in Q1 2026, its #97 holding.
  • Argent Trust Co first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
  • Argent Trust Co's Amgen position peaked at $8.63M in Q2 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.